This site complies with the HONcode standard for trustworthy health information:
verify here.

Rewarding for
you and us
Defeat Diabetes Foundation

Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300
Madeira Beach, FL 33708

Research » Inhaled Insulin

Search our News Articles Archives for diabetes and health news. Search by word or phrase. The latest article will appear first.

Intranasal Insulin Boosts Cognitive Function

Posted: Saturday, January 28, 2012

Pooled data suggest that intranasal insulin may have a positive effect on cognition in both impaired and normal subjects.

Is Inhaled Insulin Closer to Reality?

Posted: Monday, July 11, 2011

New data on the inhalable insulin product Technosphere Insulin Afrezza, from MannKind Corp., indicate that the treatment confers no discernible risk for increased cardiovascular (CV) events, while another study examined patient satisfaction with this type of drug.

EASD: AFRESA® Phase 3 Data Show Sustained Glycemic Control, Normal Lung Function in Patients over Four Years of Treatment

Posted: Wednesday, October 07, 2009

Long-term study in adults with Type 2 diabetes presented at the 45th annual meeting of the European Association for the Study of Diabetes.

The Most Effective Therapy for Diabetes Induced Alzheimer's

Posted: Wednesday, September 02, 2009

"Exercise is the most potent insulin-sensitizing agent we have," said Dr. Suzanne Craft, a geriatrician and Alzheimer’s researcher at the Veterans Administration Puget Sound Health Care System, Seattle, Washington.

Inhaled Insulin AFRESA(R) Controls Post-Meal Sugar Levels with Less Weight Gain and Hypoglycemia

Posted: Wednesday, June 17, 2009

The findings of two 52-week studies show that the investigational ultra rapid acting insulin AFRESA® (insulin human [rDNA origin]) Inhalation Powder combined with basal insulin is comparable to standard of care therapies in controlling post-meal blood sugar levels, and also results in significantly less weight gain and risk of hypoglycemia for adult patients with diabetes.

Intranasal Insulin Lowers Food Intake in Men, Improve Memory Function in Women

Posted: Wednesday, February 27, 2008

Insulin administered intranasally, acutely decreases food intake in men but not women and in contrast, the compound improves memory function in women but not men according to a new study.

Insulin Reduces Mortality in Patients With ACS and Hyperglycemia

Posted: Thursday, December 13, 2007

Insulin treatment of nondiabetic patients with acute coronary syndrome (ACS) and hyperglycemia is associated with reduced risk of death in the first 30 days.

Exubera Inhaled Insulin Is No Longer Available

Posted: Friday, October 26, 2007

Gone is the insulin bong as Pfizer announces they have spent 2.8 billion on the marketing and development of the first inhaled insulin, but have received just 12 million in sales in 2007. This will be a great opportunity to educate those patients using Exubera.

Advantages Seen With Next New Inhaled Insulin

Posted: Thursday, October 11, 2007

New inhaled insulin shows less glucose excursions after meals then injected insulin.

Is Inhaled Insulin Still Safe After 2 Years?

Posted: Thursday, May 03, 2007

The safety of inhaled insulin is holding up at 2 years in an ongoing study, with adverse pulmonary effects being small, occurring early, and proving reversible on cessation of the drug.